Sphera Funds Management Ltd. 89bio, Inc. Transaction History

Sphera Funds Management Ltd.

$363 Million
Q2 2025

A detailed history of Sphera Funds Management Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 205,675 shares of ETNB stock, worth $1.86 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

205,675

Previous 618,343 66.74%

Holding current value

$1.86 Million

Previous $4.5 Million 55.08%

% of portfolio

0.56%

Previous 1.18%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$4.83 - $10.57 $1.99 Million - $4.36 Million	-412,668 Reduced 66.74%	205,675 $2.02 Million
Q1 2025 May 15, 2025	BUY	$6.18 - $11.66 $381,991 - $720,716	61,811 Added 11.11%	618,343 $4.5 Million
Q4 2024 Feb 14, 2025	BUY	$7.03 - $10.05 $140,494 - $200,849	19,985 Added 3.72%	556,532 $4.27 Million
Q3 2024 Nov 14, 2024	BUY	$7.36 - $9.66 $73,600 - $96,600	10,000 Added 1.9%	536,547 $3.97 Million
Q2 2024 Aug 14, 2024	BUY	$7.31 - $10.9 $77,961 - $116,248	10,665 Added 2.07%	526,547 $4.22 Million
Q1 2024 May 15, 2024	BUY	$8.13 - $13.77 $871,601 - $1.48 Million	107,208 Added 26.23%	515,882 $6 Million
Q4 2023 Feb 14, 2024	BUY	$6.66 - $16.03 $595,224 - $1.43 Million	89,373 Added 27.99%	408,674 $4.56 Million
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $2.78 Million - $3.58 Million	184,301 Added 136.52%	319,301 $4.93 Million
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $1.91 Million - $2.97 Million	135,000 New	135,000 $2.56 Million
Q4 2022 Feb 14, 2023	SELL	$5.52 - $12.73 $2.64 Million - $6.09 Million	-478,184 Reduced 72.59%	180,600 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $7.0 $630,527 - $1.46 Million	208,784 Added 46.4%	658,784 $3.81 Million
Q2 2022 Aug 15, 2022	BUY	$2.09 - $4.02 $940,499 - $1.81 Million	450,000 New	450,000 $1.45 Million
Q1 2021 May 17, 2021	SELL	$20.22 - $26.73 $1.41 Million - $1.87 Million	-69,939 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.16 - $28.08 $254,760 - $308,880	11,000 Added 18.66%	69,939 $1.7 Million
Q3 2020 Nov 12, 2020	BUY	$24.34 - $38.82 $1.43 Million - $2.29 Million	58,939 New	58,939 $1.51 Million

Others Institutions Holding ETNB

# of Institutions

212

Shares Held

162M

Call Options Held

289K

Put Options Held

1.6M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $420M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. 89bio, Inc. Transaction History